Free Trial

Microbot Medical (MBOT) Competitors

Microbot Medical logo
$2.48 -0.04 (-1.59%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$2.49 +0.01 (+0.40%)
As of 07/15/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MBOT vs. OM, NPCE, CLPT, NNOX, SKIN, ZIMV, BSGM, SNWV, DRTS, and NYXH

Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Outset Medical (OM), NeuroPace (NPCE), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Beauty Health (SKIN), ZimVie (ZIMV), Biosig Technologies (BSGM), Sanuwave Health (SNWV), Alpha Tau Medical (DRTS), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry.

Microbot Medical vs. Its Competitors

Outset Medical (NASDAQ:OM) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

Outset Medical presently has a consensus price target of $29.50, indicating a potential upside of 63.16%. Microbot Medical has a consensus price target of $9.00, indicating a potential upside of 262.90%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than Outset Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00
Microbot Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Outset Medical has a beta of 2.15, meaning that its stock price is 115% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500.

In the previous week, Microbot Medical had 2 more articles in the media than Outset Medical. MarketBeat recorded 3 mentions for Microbot Medical and 1 mentions for Outset Medical. Outset Medical's average media sentiment score of 1.87 beat Microbot Medical's score of 0.90 indicating that Outset Medical is being referred to more favorably in the media.

Company Overall Sentiment
Outset Medical Very Positive
Microbot Medical Positive

Microbot Medical has lower revenue, but higher earnings than Outset Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$113.69M2.82-$127.98M-$29.15-0.62
Microbot MedicalN/AN/A-$11.44M-$0.65-3.82

16.3% of Microbot Medical shares are owned by institutional investors. 2.4% of Outset Medical shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Microbot Medical has a net margin of 0.00% compared to Outset Medical's net margin of -98.74%. Microbot Medical's return on equity of -110.27% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-98.74% -143.62% -37.50%
Microbot Medical N/A -110.27%-94.20%

Summary

Microbot Medical beats Outset Medical on 8 of the 15 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBOT vs. The Competition

MetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$91.67M$6.83B$5.62B$9.29B
Dividend YieldN/A1.28%4.25%4.03%
P/E Ratio-3.8225.9728.5719.58
Price / SalesN/A61.62423.3293.40
Price / CashN/A20.3636.0257.93
Price / Book14.594.638.135.54
Net Income-$11.44M$174.76M$3.24B$257.73M
7 Day Performance-0.80%-3.25%0.16%-0.08%
1 Month Performance1.22%-0.33%5.95%8.09%
1 Year Performance126.48%0.36%26.09%13.02%

Microbot Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBOT
Microbot Medical
2.107 of 5 stars
$2.48
-1.6%
$9.00
+262.9%
+126.5%$91.67MN/A-3.8220
OM
Outset Medical
1.7295 of 5 stars
$20.45
-2.2%
$27.00
+32.0%
-71.4%$370.40M$113.69M0.00520Positive News
Analyst Forecast
NPCE
NeuroPace
3.5288 of 5 stars
$10.22
-1.6%
$15.50
+51.7%
+21.4%$340.78M$79.91M0.00170
CLPT
ClearPoint Neuro
1.8311 of 5 stars
$11.80
+0.9%
$25.00
+111.9%
+48.3%$327.47M$31.39M0.00110
NNOX
Nano-X Imaging
2.1269 of 5 stars
$5.12
-3.8%
$9.50
+85.5%
-44.7%$307.38M$11.28M0.00190Positive News
SKIN
Beauty Health
0.289 of 5 stars
$2.20
-3.5%
$1.42
-35.6%
-22.3%$287.27M$334.30M0.001,030
ZIMV
ZimVie
2.0053 of 5 stars
$9.43
-8.0%
$16.33
+73.2%
-53.8%$285.43M$449.75M12.981,770
BSGM
Biosig Technologies
1.9134 of 5 stars
$11.55
+11.0%
$10.00
-13.4%
+955.3%$284.14M$40K0.0050News Coverage
Gap Up
High Trading Volume
SNWV
Sanuwave Health
N/A$33.17
+4.8%
N/AN/A$270.79M$32.63M0.0040
DRTS
Alpha Tau Medical
3.1362 of 5 stars
$3.29
+3.8%
$8.00
+143.2%
+48.6%$268.88MN/A0.0080Positive News
NYXH
Nyxoah
2.8622 of 5 stars
$7.86
+1.2%
$14.50
+84.5%
-14.7%$264.65M$4.89M0.00110

Related Companies and Tools


This page (NASDAQ:MBOT) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners